DPM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sumitomo Pharma Co Ltd

Watchlist Manager

Watchlist

Price: 8.046 EUR 0.21% Market Closed

Market Cap: €12.1B

S	Sumitomo Pharma Co Ltd XMUN:DPM	JP
C	Cadeler A/S F:CA2	DK
N	Nomura Real Estate Master Fund Inc F:8BQ	JP
S	Sumitomo Pharma Co Ltd F:DPM	JP
	Telecom Italia SpA F:TQI	IT
C	Ceres Power Holdings PLC F:CFJA	UK
M	MOL Magyar Olajes Gazipari Nyrt PSE:MOL	HU
B	Basler AG XMUN:BSL	DE
B	Basler AG DUS:BSL	DE
T	Triplepoint Venture Growth BDC Corp F:6JS	US
N	NeuroMetrix Inc F:NLZ	US
	Freshworks Inc F:7DF	US
	LiveOne Inc F:351	US
	Carel Industries SpA F:CIG	IT
	Polar Power Inc F:PPW	US
A	Admiral Group PLC F:FLN	UK
S	Serco Group PLC XMUN:SEO	UK

Profitability Summary

Sumitomo Pharma Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

68% > 59%

Healthy Operating Margin

28%

Negative 3Y Average Operating Margin

-30%

Operating Margin is Increasing

-10% > 28%

Healthy Net Margin

24%

Negative 3Y Average Net Margin

-32%

Net Margin is Increasing

-13% > 24%

Healthy Free Cash Flow Margin

10%

Negative 3Y Average Free Cash Flow Margin

-28%

Free Cash Flow Margin is Increasing

0% > 10%

Exceptional ROE

48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-9%

ROIC is Increasing

-11% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.